These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32972983)

  • 41. miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.
    Wang G; Tao X; Peng L
    Bioengineered; 2022 May; 13(5):12985-12997. PubMed ID: 35611851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.
    Kim J; Hwangbo C; Hu X; Kang Y; Papangeli I; Mehrotra D; Park H; Ju H; McLean DL; Comhair SA; Erzurum SC; Chun HJ
    Circulation; 2015 Jan; 131(2):190-9. PubMed ID: 25336633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting Jak-Stat Signaling in Experimental Pulmonary Hypertension.
    Yerabolu D; Weiss A; Kojonazarov B; Boehm M; Schlueter BC; Ruppert C; Günther A; Jonigk D; Grimminger F; Ghofrani HA; Seeger W; Weissmann N; Schermuly RT
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):100-114. PubMed ID: 33052714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.
    Ghatnekar A; Chrobak I; Reese C; Stawski L; Seta F; Wirrig E; Paez-Cortez J; Markiewicz M; Asano Y; Harley R; Silver R; Feghali-Bostwick C; Trojanowska M
    Am J Pathol; 2013 Jun; 182(6):2391-406. PubMed ID: 23583651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension.
    Zhang R; Shi L; Zhou L; Zhang G; Wu X; Shao F; Ma G; Ying K
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L574-83. PubMed ID: 24464808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
    Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
    Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.
    Xu W; Erzurum SC
    Compr Physiol; 2011 Jan; 1(1):357-72. PubMed ID: 23737177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blueberry extract decreases oxidative stress and improves functional parameters in lungs from rats with pulmonary arterial hypertension.
    Türck P; Fraga S; Salvador I; Campos-Carraro C; Lacerda D; Bahr A; Ortiz V; Hickmann A; Koetz M; Belló-Klein A; Henriques A; Agostini F; da Rosa Araujo AS
    Nutrition; 2020 Feb; 70():110579. PubMed ID: 31743815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
    Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
    Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension.
    He YY; Yan Y; Jiang X; Zhao JH; Wang Z; Wu T; Wang Y; Guo SS; Ye J; Lian TY; Xu XQ; Zhang JL; Sun K; Peng FH; Zhou YP; Mao YM; Zhang X; Chen JW; Zhang SY; Jing ZC
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32513782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signalling.
    Kurakula K; Sun XQ; Happé C; da Silva Goncalves Bos D; Szulcek R; Schalij I; Wiesmeijer KC; Lodder K; Tu L; Guignabert C; de Vries CJM; de Man FS; Vonk Noordegraaf A; Ten Dijke P; Goumans MJ; Bogaard HJ
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31273046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?
    Nie X; Shen C; Tan J; Wu Z; Wang W; Chen Y; Dai Y; Yang X; Ye S; Chen J; Bian JS
    Circ Res; 2020 Oct; 127(9):1138-1152. PubMed ID: 32752980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxia-inducible factor signaling in pulmonary hypertension.
    Pullamsetti SS; Mamazhakypov A; Weissmann N; Seeger W; Savai R
    J Clin Invest; 2020 Nov; 130(11):5638-5651. PubMed ID: 32881714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial cells in the pathogenesis of pulmonary arterial hypertension.
    Evans CE; Cober ND; Dai Z; Stewart DJ; Zhao YY
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33509961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.